A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. (Record no. 15599856)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01933 a2200529 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514231118.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200510s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0923-7534 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1093/annonc/mdi227 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rea, D W |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20051004 |
| 245 00 - TITLE STATEMENT | |
| Title | A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
| Date of publication, distribution, etc. | Jul 2005 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1123-32 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Area Under Curve |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Camptothecin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Capecitabine |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cohort Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colorectal Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Deoxycytidine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorouracil |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Irinotecan |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nortier, J W R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ten Bokkel Huinink, W W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Falk, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Richel, D J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Maughan, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Groenewegen, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smit, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Steven, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bakker, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Semiond, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kerr, D J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Punt, C J A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of oncology : official journal of the European Society for Medical Oncology |
| Related parts | vol. 16 |
| -- | no. 7 |
| -- | p. 1123-32 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdi227">https://doi.org/10.1093/annonc/mdi227</a> |
| Public note | Available from publisher's website |
No items available.